ConductScience.org, home

Paper · 37313463

Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing.

He Y and 11 others. Front Oncol, 2023. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing. Papers, record 37313463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37313463

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing.
PubMed
Journal
Front Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.93
iCite
Revised in PubMed
2023-06-15
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1He YYonggang
2Huang WWen
3Tang YYichen
4Li YYuming
5Peng XXuehui
6Li JJing
7Wu JJing
8You NNan
9Li LLing
10Liu CChuang

1 to 10 of 12Source PubMed

See all 12 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129,081,663Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis.Onco Targets Ther2017https://conductscience.org/library/papers/29081663PubMed
227,775,650The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy.Cancers (Basel)2016https://conductscience.org/library/papers/27775650PubMed
326,206,560Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.Cancer Res2015https://conductscience.org/library/papers/26206560PubMed
427,010,960KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma.Clin Transl Gastroenterol2016https://conductscience.org/library/papers/27010960PubMed
523,396,013Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.Nat Biotechnol2013https://conductscience.org/library/papers/23396013PubMed
625,855,536Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.Nat Commun2015https://conductscience.org/library/papers/25855536PubMed
724,980,681A rising titan: TTN review and mutation update.Hum Mutat2014https://conductscience.org/library/papers/24980681PubMed
833,350,171Genetic aberrations in Chinese pancreatic cancer patients and their association with anatomic location and disease outcomes.Cancer Med2021https://conductscience.org/library/papers/33350171PubMed
922,247,021Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome.J Natl Cancer Inst2012https://conductscience.org/library/papers/22247021PubMed
1033,652,578Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy.Int J Mol Sci2021https://conductscience.org/library/papers/33652578PubMed

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42,792,994Clinical Utility of Germline Whole-Exome Sequencing Beyond Multigene Panels in Hereditary Cancer.Genes (Basel)2026https://conductscience.org/library/papers/42792994PubMed
40,285,634The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer.Cancer Sci2025https://conductscience.org/library/papers/40285634PubMed
38,378,317Fusion genes in pancreatic tumors.Trends Cancer2024https://conductscience.org/library/papers/38378317PubMed
38,201,484Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review.Cancers (Basel)2023https://conductscience.org/library/papers/38201484PubMed
37,894,437Pancreatic Cancer Health Disparity: Pharmacologic Anthropology.Cancers (Basel)2023https://conductscience.org/library/papers/37894437PubMed

Genes28

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37313463

GET https://conductscience.org/api/papers/v1/37313463/references?page=2